Markston International’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Markston International’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,673	Closed	–	–	149
2021 Q1	$0	Hold	3,673	–	–	﹤0.01%	150
2020 Q4	$3K	Hold	3,673	–	–	﹤0.01%	135
2020 Q3	$8K	Sell	3,673 -37,400	-91%	-$107K	﹤0.01%	122
2020 Q2	$147K	Hold	41,073	–	–	0.02%	92
2020 Q1	$156K	Hold	41,073	–	–	0.02%	90
2019 Q4	$124K	Buy	+41,073	New	+$107K	0.01%	93

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Markston International's BMY.RT Position: Q2 2021 in Review

Markston International sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q2 2021, closing a stake of 3,673 shares.

Markston International first reported a position in BMY.RT in Q4 2019 and held it in 6 quarters. The position peaked at $156K in Q1 2020. 8 funds tracked by Wall St. Rank hold BMY.RT as of Q2 2021.

Markston International reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q2 2021 after selling out during the quarter.
Markston International sold 3,673 Bristol-Myers Squibb Company Contingent Value Rights shares in Q2 2021.
Markston International first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 6 quarters.
Markston International's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $156K in Q1 2020.
8 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q2 2021.

Based on Markston International's 13F filing for Q2 2021, filed 5 Aug 2021.